Confused between eczema and psoriasis? Experts explain how these skin conditions differ in symptoms, causes, and treatment.

Psoriasis is a long-term skin condition that affects millions of people around the world. It causes red, dry, and scaly ...

Organon recently presented post-hoc pooled Phase 3 ADORING 1 and 2 data showing VTAMA cream achieved early, statistically significant improvements in atopic dermatitis severity and itch versus vehicle ...

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Even though having an itch is innocuous, the underlying reason you have the itch in the first place could be more disgusting ...

Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI ...

Investigational ZORYVE® (roflumilast) cream 0.05% was well tolerated with safety findings consistent with prior pediatric experience in the ...

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present results from a post-hoc sub-analysis of pooled data ...

"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms ...

A man recalls the emotional toll growing up with plaque psoriasis had on him as a teenager in an exclusive interview with ...